Swiftmerge Acquisition Corp. (IVCP)

NASDAQ: IVCP · IEX Real-Time Price · USD
+0.04 (0.37%)
At close: May 17, 2024, 4:00 PM
-0.01 (-0.09%)
After-hours: May 17, 2024, 4:00 PM EDT
Market Cap 74.21M
Revenue (ttm) n/a
Net Income (ttm) 2.60M
Shares Out 6.84M
EPS (ttm) 0.09
PE Ratio 120.44
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,754
Open 10.85
Previous Close 10.80
Day's Range 10.80 - 10.85
52-Week Range 10.00 - 12.20
Beta 0.01
Analysts n/a
Price Target n/a
Earnings Date n/a

About IVCP

Swiftmerge Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its search of target in the consumer industry. The company was incorporated in 2021 and is based in Toluca Lake, California. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Dec 15, 2021
Employees 4
Stock Exchange NASDAQ
Ticker Symbol IVCP
Full Company Profile

Financial Performance

Financial Statements


HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.

NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $ipo #Consumer--HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular ther...

10 months ago - Business Wire

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $health #Consumer--NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special pu...

1 year ago - Business Wire